Non-statin cholesterol drugs on every 2026 Kansas Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Kansas cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Blue MedicareRx Essentials$0.00/moS5726-020 | Blue MedicareRx Value$0.70/moS5726-013 | HealthSpring Assurance Rx$6.70/moS5617-118 | Wellcare Value Script$9.60/moS4802-157 | Wellcare Classic$14.70/moS4802-088 | Humana Basic Rx Plan$15.50/moS5884-109 | Humana Value Rx Plan$55.60/moS5884-203 | Blue MedicareRx Plus$67.40/moS5726-014 | SilverScript Choice$88.30/moS5601-048 | AARP Medicare Rx Saver from UHC$105.40/moS5921-369 | Humana Premier Rx Plan$116.30/moS5884-170 | AARP Medicare Rx Preferred from UHC$147.00/moS5921-405 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ezetimibegeneric Zetia | Tier 430%QL 30/30d | Tier 440%QL 30/30d | Tier 210%QL 30/30d | Tier 440% | Tier 426% | Tier 325%QL 30/30d | Tier 320%QL 30/30d | Tier 2$0.00QL 30/30d | Tier 433% | Tier 317%QL 30/30d | Tier 3$45.00QL 30/30d | Tier 2$10.00QL 30/30d |
| Repathaevolocumab | Tier 3PA20%QL 6/28d | Tier 3PA18%QL 6/28d | Tier 3PA25%QL 6/28d | Not covered | Not covered | Tier 3PA25%QL 3/28d | Tier 3PA20%QL 3/28d | Tier 3PA20%QL 6/28d | Tier 3PA18% | Tier 3PA17%QL 3/28d | Tier 3PA$45.00QL 3/28d | Tier 315%QL 3/28d |
| Praluentalirocumab | Not covered | Not covered | Not covered | Tier 3PA25% | Tier 3PA25% | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Nexletolbempedoic acid | Tier 3PA20%QL 30/30d | Tier 3PA18%QL 30/30d | Tier 3PA25%QL 30/30d | Tier 3PA25% | Tier 3PA25% | Tier 3PA25%QL 30/30d | Tier 3PA20%QL 30/30d | Tier 3PA20%QL 30/30d | Tier 318%QL 30/30d | Tier 3PA17%QL 30/30d | Tier 3PA$45.00QL 30/30d | Tier 3PA15%QL 30/30d |
| Nexlizetbempedoic acid and ezetimibe | Tier 3PA20%QL 30/30d | Tier 3PA18%QL 30/30d | Not covered | Not covered | Not covered | Tier 3PA25%QL 30/30d | Tier 3PA20%QL 30/30d | Tier 3PA20%QL 30/30d | Tier 318%QL 30/30d | Tier 3PA17%QL 30/30d | Tier 3PA$45.00QL 30/30d | Tier 3PA15%QL 30/30d |
| fenofibrategeneric Tricor | Tier 2$0.00QL 30/30d | Tier 318%QL 30/30d | Tier 210% | Tier 2$3.00 | Tier 325% | Tier 325%QL 30/30d | Tier 2$0.00QL 30/30d | Tier 2$0.00QL 30/30d | Tier 2$7.00 | Tier 2$7.00 | Tier 2$4.00QL 30/30d | Tier 2$10.00 |
| Vascepaicosapent ethyl | Tier 320%QL 120/30d | Tier 318%QL 120/30d | Not covered | Tier 440% | Tier 426% | Tier 325%QL 120/30d | Tier 320%QL 120/30d | Tier 320%QL 120/30d | Tier 433% | Tier 317% | Tier 3$45.00QL 120/30d | Tier 315% |
| icosapent ethylgeneric Vascepa | Not covered | Not covered | Tier 431% | Tier 440% | Tier 426% | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.